MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm

被引:5
|
作者
Shimura, Tatsuo [1 ]
Kofunato, Yasuhide [2 ]
Okada, Ryo [2 ]
Yashima, Rei [2 ]
Okada, Koji [3 ]
Araki, Kenichiro [3 ]
Hosouchi, Yasuo [4 ]
Kuwano, Hiroyuki [3 ]
Takenoshita, Seiichi [2 ]
机构
[1] Fukushima Med Univ, Dept Canc Biol & Elect, 1 Hikarigaoka, Fukushima 9601295, Japan
[2] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima 9601295, Japan
[3] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Gunma 3718511, Japan
[4] Gunma Prefecture Saiseikai Maebashi Hosp, Dept Surg & Laparoscop Surg, Maebashi, Gunma 3710821, Japan
关键词
IPMN; MIB-1; Ki-67; invasive IPMN; mural nodule;
D O I
10.3892/mco.2016.908
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite strict criteria for the observation of intraductal papillary mucinous neoplasm (IPMN), it remains difficult to distinguish invasive IPMN from non-invasive IPMN. The aim of the present study was to identify an indicator of invasive IPMN. The present study retrospectively evaluated 53 patients (28 with non-invasive and 25 with invasive IPMN) who underwent resection of IPMN, and examined the usefulness of the MIB-1 labeling index as an indicator of invasive IPMN. The MIB-1 labeling indexes in patients with invasive IPMN were significantly higher compared with those with non-invasive IPMN (P<0.001). A receiver operating characteristic curve revealed that the area under the curve was 0.822. These results suggested that a cut-off level for the MIB-1 labeling index should be set to 15.5% to distinguish invasive from non-invasive IPMN. A multivariate analysis using a logistic regression model revealed the MIB-1 labeling index (hazard ratio, 18.692; 95% confidential interval, 4.171-83.760; P<0.001) and the existence of mural nodules (hazard ratio, 6.187, 95% confidential interval, 1.039-36.861; P=0.045) were predictive factors for invasive IPMN. However, no statistically significant differences were observed between patients with a lower MIB-1 labeling index and patients with a higher MIB-1 labeling index (P=0.798). The MIB-1 labeling index must be considered as a candidate for the classification of IPMN.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
  • [21] Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
    Pizarro, CB
    Oliveira, MC
    Coutinho, LB
    Ferreira, NP
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (02) : 235 - 243
  • [22] PAPILLARY RENAL-CELL CARCINOMA - ASSESSMENT OF PROLIFERATIVE ACTIVITY USING PCNA AND MIB-1 (KI-67) AND CORRELATION WITH CLINICOPATHOLOGICAL FINDINGS
    DEPERALTAVENTURINA, MN
    AMIN, MB
    KEOLEIAN, CM
    SCHULTZ, DS
    KUBUS, JJ
    LINDEN, MD
    ZARBO, RJ
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (04): : 241 - 247
  • [23] Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II
    Prat-Acin, Ricardo
    Juliana Guarin-Corredor, Maria
    Galeano-Senabre, Inma
    Ayuso-Sacido, Angel
    Vera-Sempere, Francisco
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 86 : 32 - 37
  • [24] The Prognostic Role of Ki-67/MIB-1 in Cervical Cancer: A Systematic Review with Meta-Analysis
    Pan, Denghua
    Wei, Kanglai
    Ling, Yanxin
    Su, Shitao
    Zhu, Meilin
    Chen, Gang
    MEDICAL SCIENCE MONITOR, 2015, 21 : 882 - 889
  • [25] Preoperative Predictive Features of Invasive Carcinoma Among Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Kazami, Yusuke
    Arita, Junichi
    Nishioka, Yujiro
    Kawaguchi, Yoshikuni
    Ichida, Akihiko
    Ishizawa, Takeaki
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Nakai, Yousuke
    Koike, Kazuhiko
    Hasegawa, Kiyoshi
    PANCREAS, 2022, 51 (06) : 642 - 648
  • [26] EXPRESSION OF KI-67 (MIB-1) AND GLUT-1 PROTEINS IN NON-ADVANCED PROSTATIC CANCER
    Luczynska, Elzbieta
    Gasinska, Anna
    Wilk, Waclaw
    POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 272 - 277
  • [27] Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody
    Mastronardi, L
    Guiducci, A
    Spera, C
    Puzzilli, F
    Liberati, F
    Maira, G
    JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (02) : 107 - 111
  • [28] In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma
    Chou, SJ
    Chen, CM
    Harn, HJ
    Chen, CJ
    Liu, YC
    JOURNAL OF SURGICAL RESEARCH, 2001, 99 (01) : 75 - 83
  • [29] N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
    Nieminen, Heini
    Nummela, Pirjo
    Satomaa, Tero
    Heiskanen, Annamari
    Hiltunen, Jukka O. O.
    Kaprio, Tuomas
    Seppanen, Hanna
    Hagstrom, Jaana
    Mustonen, Harri
    Ristimaki, Ari
    Haglund, Caj
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Analysis of immunhistochemical expression of PCNA (proliferating cellular nuclear antigen) and MIB-1 (Ki-67 antigen) as a prognostic indicator for renal cell carcinoma
    Onda, H
    Yasuda, M
    Serizawa, A
    Osamura, RY
    Kawamura, N
    AKTUELLE UROLOGIE, 2000, 31 : 64 - 67